One of the most popular and well-known names in the biotech world is definitely Biogen (BIIB-Analyst Report). This large cap stock has been a staple of investor portfolios in the biotechnology space for some time, while it is also one of the behemoths of the sector, closing in on $100 billion in market cap.BIIB might be due for a breather […]
Benchmarks ended the first trading day of the week in the red, dragged down by declines in technology stocks. Drop in airline stocks also weighed on the broader markets. The lack of progress related to Greece’s debt deal with its creditors also dented investor sentiment. Meanwhile, Friday’s upbeat jobs data continued to intensify concerns about rate hike as early as […]
Benchmarks ended the last trading day of the week in the red following Janet Yellen’s comments that it would be appropriate to raise interest rates sometime this year. Yellen said the economy is well positioned to grow even if weak economic data had indicated the economy was not on a solid footing. Meanwhile, an increase in consumer price index raised […]
Eleven Biotherapeutics (EBIO – Snapshot Report) suffered a huge setback with its lead pipeline candidate failing in a late-stage study. Meanwhile, companies like bluebird (BLUE – Snapshot Report), Agios (AGIO – Snapshot Report) and Acceleron (XLRN – Snapshot Report) all got encouraging news on the regulatory front. Achillion (ACHN – Snapshot Report) struck a collaboration agreement with Johnson & Johnson […]
Markets added modest gains on Friday amid discouraging economic data. A flurry of weaker-than-expected economic reports increased expectations that the Fed will refrain from raising interest rates in the near term, which eventually helped the S&P 500 and the Dow end marginally higher. The day’s minute gains were enough for the S&P 500 to close at a record level for […]
Benchmarks snapped a two-day losing streak on Thursday following easing in bond yields and gains in technology stocks. Meanwhile, a less-than-expected rise in initial claims numbers on Thursday has set the tone for crucial total non-farm payroll data scheduled for release today. Investors are looking forward to the nonfarm payroll report to gauge the timing of the rate hike.For a […]
Markets made a strong comeback on Friday as investors added beaten down stocks to their portfolios. Moreover, General Motors and Ford posted better-than-expected U.S. auto sales numbers. Economic data was mixed. Each benchmarks gained at least 1%, limiting the weekly losses.For a look at the issues currently facing the markets, make sure to read today’s Ahead of Wall Street articleThe […]
Benchmarks finished in negative territory on Wednesday on weak GDP report while Fed retained the data-dependent stance regarding rate hike. The U.S. economy expanded at a slower pace in the first quarter due to severe winter weather, major disputes in ports and stronger dollar that adversely affected export-oriented companies. Meanwhile, investors continued to keep an eye on first quarter earnings […]
Benchmarks ended Thursday’s choppy trading session slightly lower following mixed economic data and Fed officials comments on interest rate hike. Upbeat earnings results, well received initial public offerings and rise in oil prices failed to help benchmarks close in the green. While, about two third of the Dow components ended in the red, seven out of ten sectors of the […]
Improved consumer-price index failed to cheer markets as the benchmarks settled in the red for the second consecutive day. While utilities sector dragged benchmarks lower, strong housing numbers could only boost the housing stocks. Benchmarks had gained momentarily, but they gave up all their initial gains after the dollar started moving higher against the euro. Tuesday also marked the second […]
